Global Cryptococcal Meningitis Screening

To determine feasibility and cost of prevention of Cryptococcal disease in African, Asian and Central American countries via the implementation of a “screen-and-treat” strategy. This strategy will support and guide policy makers in the rollout and sustained management of a successful “screen-and-treat” program. This project is expanding to an additional 8-12 countries.
Funding Partners:
  • Pfizer Inc.
Program Partners:
  • CDC's National Center for Emerging and Zoonotic Infectious Diseases
Program Location:
  • Botswana